Moderna’s new COVID-19 vaccine for South African variant ready for human testing, company says

Moderna on Wednesday announced that the COVID-19 vaccine it recently developed to address a concerning new coronavirus variant first identified in South Africa is ready to be tested in people in clinical trials.